Go back

Opportunity profile: New lymphoma funder presses ahead

Image: Ed Uthman [CC BY 2.0], via Flickr

Originality and innovation are watchwords for one of Europe’s newest cancer research funders

Top tips:

  • Lymph&Co particularly appreciates interdisciplinary applications
  • Lead applicants should have a strong publication record in lymphoma research or be able to demonstrate their expertise in the field in another way
  • The charity welcomes fundamental, translational and clinical research bids
  • Innovation is highly prized but where there is little precedent in the literature, preliminary data should be included

The charity Lymph&Co was formed in 2016 with much of the initial impetus coming from one of its co-founders, the Dutch royal family member Bernhard van Oranje. After recovering from lymphoma, van Oranje learnt that there was no dedicated Dutch fund for lymphoma research and set to work.

This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com